International Assets Investment Management LLC Has $652,000 Position in CME Group Inc. $CME

International Assets Investment Management LLC boosted its holdings in CME Group Inc. (NASDAQ:CME) by 3.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,364 shares of the financial services provider’s stock after purchasing an additional 76 shares during the quarter. International Assets Investment Management LLC’s holdings in CME Group were worth $652,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of CME. Wayfinding Financial LLC acquired a new stake in CME Group in the 1st quarter valued at $25,000. Webster Bank N. A. grew its position in CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares during the period. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 55 shares during the period. Highline Wealth Partners LLC grew its position in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the period. Finally, Golden State Wealth Management LLC grew its position in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 98 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 262 shares of the stock in a transaction dated Thursday, September 25th. The shares were bought at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the purchase, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares in the company, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CME has been the subject of several research reports. Jefferies Financial Group reduced their price target on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research report on Friday, October 10th. Oppenheimer raised their price objective on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Piper Sandler raised their price objective on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. TD Cowen raised their price objective on CME Group from $281.00 to $288.00 and gave the company a “hold” rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and a consensus price target of $283.71.

CME Group Price Performance

Shares of NASDAQ:CME opened at $268.61 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock’s fifty day simple moving average is $266.80 and its two-hundred day simple moving average is $271.48. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The stock has a market cap of $96.80 billion, a PE ratio of 26.00, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $2.56 EPS. As a group, analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is presently 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.